Skip to content
★ Sign in to follow
JS

Jake St Philip

CEO
Biolase, Inc
Total declarations
9
Company
1
▲ Purchases (9 ops.)
€78k
▼ Sales (0 ops.)
—

Latest filing published 03 Jun 2008 for BIOLASE, INC, €409.

Insider track record

Disclosed buys
9
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
9

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jake St Philip: trading record in brief

This profile gathers the share dealings of Jake St Philip in Biolase, Inc. Between 12 May 2008 and 30 May 2008, the trades on record add up to 9 filings.

On the market, this insider has only ever bought: 9 purchases, €78k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €1,251.

The latest filing, published on 3 June 2008, reports an open-market purchase of €409 in Biolase, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jake St Philip

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    CEOExecutivesBiolase, Inc
    636 USD0SEC
    200 shares@ US$3.18Common StockSEC:0001209191-08-034638:0
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    1,920 USD0SEC
    600 shares@ US$3.20Common StockSEC:0001209191-08-034638:1
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    642 USD0SEC
    200 shares@ US$3.21Common StockSEC:0001209191-08-034638:2
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    12,880 USD0SEC
    4,000 shares@ US$3.22Common StockSEC:0001209191-08-034638:3
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    323 USD0SEC
    100 shares@ US$3.23Common StockSEC:0001209191-08-034638:4
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    1,944 USD0SEC
    600 shares@ US$3.24Common StockSEC:0001209191-08-034638:5
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    13,975 USD0SEC
    4,300 shares@ US$3.25Common StockSEC:0001209191-08-034638:6
    Canonical exit: 28 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    73,750 USD0SEC
    25,000 shares@ US$2.95Common StockSEC:0001209191-08-029861:0
    Canonical exit: 10 Aug 2008 (T+90)
  • ▲
    CEOExecutivesBiolase, Inc
    14,700 USD0SEC
    5,000 shares@ US$2.94Common StockSEC:0001209191-08-029861:1
    Canonical exit: 10 Aug 2008 (T+90)

9 of 9 declarations